Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Trending New Challenges and Emerging Technologies in Vaccines and Vaccination
- Global Vaccines Congress 2018


Global Vaccines Congress 2018
The 3rd Global Congress on Vaccines and Vaccination was organized on November 14-15, 2018 at the Hotel Mercure Roma West, Rome Italy. The conference was marked with the attendance of Editorial Board Members of supported Allied Academies Journals, Scientists, young and brilliant researchers and talented student communities representing more than 10 countries, who made this conference fruitful and productive.

This conference was based on the Theme - "Trending New Challenges and Emerging Technologies in Vaccines and Vaccination” which included the following scientific tracks:

       Antibodies and Vaccination

Types of Vaccines

Clinical & Vaccine Immunology

Vaccine Preventable Diseases
Plant-Based Vaccines

Veterinary Vaccines

Human Vaccines

Bacterial and Viral Vaccines

Vaccines and autism

Travel and Edible Vaccines

Hepatitis Vaccines

Cancer Vaccines

HIV/AIDS Vaccines

Biotechnology and Modern Vaccine Technology

Immunizations against Drugs                                                

Vaccine Development and Production

Fish vaccines

Adjuvants and delivery Technologies

Current research and future difficulties


Global Vaccines Congress 2018 was moderated by Oksana Ryabinina Debrah (Greater Accra Regional Hospital, Ghana) on the First and Second day of the Conference.

We are grateful to our Organizing Committee Members for their generous support and suggestions for the conference.


The conference proceeded through various Scientific Sessions and plenary lectures, of which the following topics were highlighted as Keynote Presentations and oral presentation:



·         Making immunization in a tradition presented by

           Harshit Jain, McCann Health,                                   

           United Kingdom



·         Relationship between cervical epithelial cell abnormalities and co-infection with Herpes simplex virus and Human papillomavirus among unscreened women in Ghana by

            Oksana Ryabinina Debrah, Greater Accra Regional Hospital, Ghana



·         The growing vaccines hesitancy - communication aspects and challenges

         by  Mitja Vrdelja, National Institute of Public Health, Slovenia


·         Title: Potential of some invertebrates venomous as therapeutic tools by

              Mamdouh I Nassar, Cairo University, Egypt


and some more..


The Conference was successfully completed with the support of our Collaborator   Asociacion Mundial de Diabeticos, Italy.

 Allied Academies has taken the grand privilege of felicitating Global Vaccines Congress 2018 Organizing Committee, Editorial Board Members and Keynote Speakers who supported the success of this event.

The esteemed guests, Keynote speakers, well-known researchers, and delegates shared their innovative research and vast experience through their presentations at the podium of Global Vaccines Congress 2018. We are glad to inform that all accepted abstracts for the conference have been published in the Archives of General Internal Medicine as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique and positive feedback from the conference, Allied Academies would like to announce the commencement of the "6th  Global Congress on Vaccines and Vaccination" which is being organized during September 23-24, 2019 in Dubai,UAE.



About Conference

 Allied Academies is a scientific association known for promoting scientific temperament and has been performing very well in Business and Management and is a perfect platform for our readers. It is established in the year 1997. The main aim is making the information on Science and Technology. It is a specialized medical and science publisher that operates in collaboration with the association and societies.  This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario (CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), and The Canadian Society of Internal Medicine (CSIM). Global Vaccines Congress 2018 invites all the participants from all over the world to attend "3rd Global Congress on Vaccines and Vaccination”, on November 14-15,Rome,Italy.

This meeting makes a stage for Policy-creators, Scientists, agents and leaders in Vaccine and Vaccination to display their most recent research and find out about all the inovative advancements in Vaccines and Vaccination. Real subjects talked about are Latest developed vaccines, Production and effectiveness of vaccines, Types of vaccines, Veterinary vaccines,Human vaccines, Vaccines against drugs, Vaccines and autism, Vaccines for unconventional diseases,plant-derived vaccines, Vaccines safety and efficiency, Fish Vaccines,Current research and future challenges in vaccines, Society and cultural aspects of vaccines.

Why to attend???

Global Vaccines Congress 2018 is aimed to give an opportunity that with scholars from around the world focused on learning about Vaccines & Vaccination and its advances; this is the best opportunity to reach the largest assemblage of participants from the Vaccines & Vaccination community. It provide an explicit platform for presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Vaccines & Vaccination are hallmarks of this conference.

Target Audience:

  • Researchers & Scientists related to Vaccine R&D
  • Deans and Professors
  • Directors, CEOs, Presidents and Vice Presidents
  • University Faculty
  • Medical Schools/Colleges
  • Nursing Schools/Colleges
  • Associations and Societies related to Vaccine R&D
  • Vaccination Programme Organising Government and Non-government Organisations
  • Business Entrepreneurs
  • Medical Devices Manufacturing Companies
  • Vaccine Manufacturing Companies
  • Vaccine Developers and Investigators



Welcome message


Session 1: Antibodies and Vaccination

An antibody is an organic arrangement that gives dynamic obtained invulnerability to a specific ailment. An immunization commonly contains an operator that highlights an infection causing microorganism and is regularly produced using debilitated types of the small scale life form, its poisons, or one of its surface proteins. They make insusceptibility against a disease. A Traditional antibody comprises of specialists that take after the ailment causing life form. At the point when these specialists enter the human body, they invigorate the resistant framework to perceive these operators as outside and annihilate them. It additionally influences the invulnerable framework to recollect these outside operators with the goal that they can perceive and pulverize the genuine live destructive germs. An immunization can be managed into the body through infusions, by mouth or by aerosol.

Following are the issues significantly examined in antibodies.

•            Vaccine Safety

•            Vaccine Work

•            Vaccine Type

•            Vaccine Ingredients

Session 2 : Types of Vaccines

Contingent on the procedures used to diminish the danger of sickness caused by an immunization, while holding their capacity to prompt a gainful invulnerable reaction they are ordered into different kinds. The human antibodies against infections were made utilizing weaker or constricted infections through a smallpox immunization is made of cowpox, a poxvirus sufficiently comparative to smallpox infection to make invulnerability. A few unique procedures are engaged with immunization creation in view of which they are ordered into various kinds.

•            Live constricted immunizations

•            Inactivated/Killed antibodies

•            Toxoid

•            Subunit/Conjugate

•            Heterotypic

•            Valance

Session 3: Clinical & Vaccine Immunology

Clinical insusceptibility manages the investigation of sicknesses and disarranges that happens because of the frail resistant framework which incorporates variant activity, disappointment, and irregular development of the cell components of the invulnerable framework. It likewise manages infections identified with different frameworks, where invulnerable reactions assume a part. Antibody Immunology manages the investigation of immunizations and their immunological impacts. It manages immunological Vaccines for their amalgamation, advancement and restorative allure and similarity.

•            Cellular and Humoral immunity

•            Immuno-epidemiology

•            Immunological and Immune-mediated disorders

•            Microbial immunology

•            Viral immuno-pathogenesis

Session 4: Vaccine Preventable Diseases
A counteracting agent preventable disorder is an overwhelming illness for which a convincing preventive inoculation exists. If a man gets an inoculation preventable affliction and passes on from it, the end is seen as a counteracting agent preventable passing.

•                      Diphtheria

•                      Haemophilus influenza serotype b infection

•                      Hepatitis B

•                      Meningitis

•                      Tuberculosis

•                      Yellow fever

•                      Mumps

•                      Measles

Session 5: Plant-Based Vaccines

The Vaccines in which the coveted qualities that encode the antigen protein for antibodies articular infection are embedded into the genome of plant tissue by different strategies are named as plant-based immunizations. The most well-known strategies that are utilized to create viable plant-based antibodies are Agro bacterium-interceded quality exchange and Transformation by means of hereditarily changed plant infection. Anyway progressions in the field of science and innovation grew new methodologies, for example, agroinfiltration, biolistics, electroporation, polyethylene glycol treatment and sonication to supplant the previous strategies.

•              Plant-Based Vaccines Production

•              Direct&IndirectGene Delivery Method

•              Immunogen Design and Gene Synthesis

•              Methods to Increase the Efficiency of Gene Delivery

•              Challenges of Plant-Based Vaccines

•              Plastid transformation

Session 6: Veterinary Vaccines:

Extensive advance has been made in the generation of veterinary immunizations whether live or inactivated for creature use amid the previous two decades with the expanding utilization of nonstop cell lines as a substrate and reception of the fermenter innovation for antigen creation. These immunizations are created for organization to residential creatures or wild species by parenteral or oral courses as per antibody qualities. All the more as of late a third era of live veterinary rabies antibody has been produced utilizing recombinant innovation. Contingent on the articulation framework these immunizations are utilized either parentally or orally. Oral rabies antibodies are broadly utilized as a part of foxes in Europe and in raccoons in the USA. Trials are under route for the oral vaccination of mutts in creating nations.

•              Second-age veterinary antibodies

•              Highly immunogenic inactivated cell culture antibodies

•              Third era of live rabies antibodies

•              Live or inactivated veterinary antibodies

•              Veterinary antibodies for parenteral utilize

•              Modified live-infection veterinary antibodies for oral inoculation of wildlife

•              Recombinant veterinary antibodies for oral inoculation of natural life

•              Poultry Vaccines

Session 7: Human Vaccines:

The foremost course of rabies treatment was controlled under the supervision of Louis Pasteur, over a century back. Starting now and into the foreseeable future, rabies inoculations have constantly been among the first to benefit by progress in progress and control. As regards inoculations for human use, around 1955 there was a change from antibodies masterminded from animal nerve tissue to embryonated eggs and soon a brief timeframe later, around 1960, to modification of rabies disease to social orders of human diploid cells. The change of this neutralizer, which remains the reference inoculation in relative examinations of immunogenicity, took long years. It was first enrolled in France in 1974 and to some degree later in North America. The late 1970s and the 1980s saw the headway of an a lot of inoculations masterminded on various cell substrates, for instance, fundamental explant cells of hamster, canine or fetal calf kidney, fibroblasts of chicken creating life, or diploid cells from rhesus monkey fetal lung, ultimately cells from relentless lines (Vero cells). The making of a portion of these inoculations was stopped toward the complete of the 1980s while others have been controlled to an enormous number of patients.

•             Tuberculosis Vaccine

•             Bordetella Vaccine

•             OPV (Oral Poliovirus Vaccine)

•             Meningococcal/Menactra Vaccines

•             Smallpox Vaccine

•             Rotavirus Vaccine

•             Geriatric Vaccines

•             Pediatric Vaccination 

•             Neonate Vaccines

Session 8: Bacterial and Viral Vaccines:

Inoculation can be characterized as dynamic invulnerability created by immunization. It is invulnerability and immunologic memory like regular contamination yet without danger of sickness. There are two fundamental kinds of antibodies: live constricted and inactivated. Live weakened immunizations are created by changing a malady delivering infection or bacterium in a research facility. Antibodies got from bacterium are called as bacterial immunization and from infection is as a viral antibody. The subsequent immunization life form holds the capacity to imitate and create insusceptibility, yet more often than not does not cause sickness. Inactivated immunizations can be made out of either entire infections or microorganisms, or parts of either.

•              Vaccines against vector-borne diseases

•              Tetanus, Diphtheria, Acellular pertussis vaccine

•              Human papillomavirus vaccine

•              Vaccines formulation and technologies used in conjugate vaccines

•              Vaccines for Autoimmune skin disorders & neuropathies

Session 9: Vaccines and autism:

Immunizations might be one of the triggers for extreme introverted. Significant information exhibit invulnerable variation from the norm in numerous mentally unbalanced kids predictable with weakened protection from disease, enactment of incendiary reaction, and autoimmunity. The impeded opposition may incline to immunization damage in a mental imbalance. An inconsistent additive in youth Vaccines, thimerosal, may cause coordinate neurotoxic, invulnerable depressive, and immune system damage and add to early-beginning and relapsed extreme introverted. Live infections in measles, mumps, and rubella(MMR) may bring about perpetual contamination of the gut and trigger relapsed extreme introverted. Thimerosal infusion may potentiate MMR damage.

•              Autism-immunizations speculation

•              Live infections in measles, mumps, and rubella (MMR)

•              Vaccines containing thimerosal

•              Simultaneous organization of numerous antibodies

•              Autoimmunity in a mental imbalance

•              Depressed opposition in extreme introverted

Session 10: Travel and Edible Vaccines:

Travel immunizations are prescribed to give assurance against infections endemic to the nation of the cause or of a goal. They are proposed to secure voyagers and to forestall sickness spread inside and between nations. There is no single immunization plan that fits all voyagers. Each calendar must be individualized by the explorer's past vaccination, wellbeing status and hazard factors, the nations to be gone too, the sort and term of movement, and the measure of the time accessible before the flight. Consumable immunizations hold extraordinary guarantee as a practical, simple-to-manage, simple to store, safeguard and socioculturally promptly satisfactory antibody conveyance framework, particularly for the poor creating nations. It includes the presentation of chose wanted qualities into plants and after that promoting these modified plants to make the encoded proteins.

•              Development of edible vaccines

•              Application of edible vaccines

•              Candidates for edible vaccines

•              Advantages of edible vaccines

•              Pre-travel vaccination and its wider impact

Session 11: Hepatitis Vaccines:

Viral hepatitis is an authentic therapeutic issue wherever all around the world. Regardless, the diminishing of the distressingness and mortality as a result of vaccinations against hepatitis An and hepatitis B has been a significant fragment in the general decreasing in counteracting agent preventable contaminations. We will inspect the investigation of malady transmission, vaccination headway, and post-immunization effects of the hepatitis An and B disease. Besides, we look at tries to give hepatitis D immune response to the 350 million individuals spoiled with hepatitis B all around. Given the nonappearance of a hepatitis C counteracting agent, the various challenges going up against the age of a hepatitis C vaccination will be showed up, close by present and past immunization trials. As there is no present FDA-embraced hepatitis E vaccination, we will present immunization data that is open in whatever is left of the world. Finally, we will discuss the present challenges and request facing future endeavors for each one of the hepatitis diseases, with attempts continuing to fixate on altogether decreasing the inauspiciousness and mortality related with these bona fide defilements of the liver.

•              Hepatitis A

•              Hepatitis B

•              Hepatitis C

•              Hepatitis D

Session 12: Cancer Vaccines:

The antibodies that keep a contamination which causes disease are Preventive Cancer Vaccines. A portion of the preventive immunizations accessible incorporate the HPV and hepatitis B antibodies which avoids cervical, butt-centric, and head and neck tumors. Then again the immunizations that trigger the invulnerable framework to perceive and annihilate certain markers, or antigens, introduce on or in malignancy cells are named as Therapeutic Cancer Vaccines

•              Vector-based immunizations

•              Dendritic cell

•              Antigen immunizations

•              Tumor cell immunizations

•              Protein or Peptide Cancer Vaccines

•              Allogenic tumor antibodies

•              Autologous tumor antibodies.

•              Oncolytic Virus Immunotherapy

Session 13: HIV/AIDS Vaccines:

Some pushed organize clinical trials of HIV vaccination are nonstop. Notwithstanding the way that the creation of a convincing HIV-1 immunizer remains a gigantic test, the procedure with progress in these zones offers inspiration to be optimistic about our complete ability to control the spread of AIDS. Advancement of an HIV/AIDS vaccination has been moving back in light of the fact that built up approaches to managing counteracting agent change have not yielded an immune response.

•              Recombinant vectored vaccines.

•              Vectors vaccines

•              Replicons.

•              Vaccines against viral toxin

•              HIV Vaccine Strategies

•              T cell-based Vaccines

•              B cell-based Vaccines

•              Innate & Mucosal Immunity

•              Viral Vaccine Vectors

Session 14: Biotechnology and Modern Vaccine Technology:

Biotechnology is utilized as a part of the improvement of immunization in three diverse ways: Using an extraordinary monoclonal immunizer in the partition of unadulterated antigens,using cloned qualities for the amalgamation of antigens, orchestrated proteins utilized as antibodies. Recombinant immunizations are antibodies created from recombinant DNA Technology. They are additionally called as subunit immunizations. It is important that the cutting edge biopharmaceutical immunizations are sanely composed with substance and physical characteristics that recognize the microorganisms and makes safe reaction

•              Recombinant antibodies

•              Hydrophobic Nanoparticle Technology

•              Modern antibody detailing advancements

•              TLR Agonists

•              Surfaced Arrayed Therapeutics

•              Immunopurification

•              Cloned qualities

•              Synthetic peptides

Session 15: Immunizations against Drugs:

Medication Addiction is a significant issue around the world. One treatment being explored is immunizations against medications of mishandling. The antibodies evoked against the medication can take up the medication and keep it from achieving the reward focuses in the cerebrum. Barely any such immunizations have entered clinical trials, yet inquire about is going on apace. Numerous examinations are exceptionally encouraging and more clinical trials to turn out soon.

•              Drug particles and invulnerable framework

•              Morphine and heroin immunizations

•              Methamphetamine immunizations

•              Nicotine immunizations

•              Cocaine immunizations

•              Hapten structure, linkage science, immunogenic proteins, and adjuvants

Session 16: Vaccine Development and Production:

Antibody advancement includes a mix of open and private and it is a long and confounded process which goes on for around 10-15 years. Not all immunizations that are planned gets authorized just modest level of hopeful antibody are authorized. This influences the antibody to innovative work costs higher. Antibodies are first outlined in labs and measures are made with creatures before they are tried with people. The immunization creation cycle is very unique in relation to a pharmaceutical item advancement since antibodies are natural items produced using microorganisms. The testing factors which makes the immunization improvement minimal confused incorporates the distinguishing proof of appropriate antigens, conveyance strategies which are adequate, adjuvants,difficulties in assembling.

•              Exploratory stage

•              Pre-clinical improvement

•              Clinical Development

•              Clinical Development of Pandemic Vaccines

•              Regulatory endorsement

•              Manufacturing process

•              Quality control

Session 17: Fish vaccines:

Vaccination accepts a basic part of immense scale business point developing. Generally speaking, precisely made inoculations in light of inactivated bacterial pathogens have ended up being especially viable in point. Less mechanically available viral antibodies and no parasite vaccinations exist. Extensive feasibility data is available for new fish vaccinations and pushed development has been executed. Fish antibodies can be passed on a comparable way we immunize warm-blooded animals. Fish can be immunized by splashing in a counteracting agent for a concise time span.

•              Oral Vaccination

•              Immersion Vaccination

•              Injection Vaccination

•              Vaccination Technique

Session 18: Adjuvants and delivery Technologies:

Vaccination adjuvants are relied upon to upgrade the adaptable safe responses to antigens. Adjuvants exhibit their things through different instruments. A couple of adjuvants fill in as movement structures that give prompting of the safe system. Immunologic adjuvants are added to antibodies for the induction of the response of resistant structure to the goal antigen, yet clearly don't give invulnerability. Adjuvants may act in various ways to deal with show an antigen in the safe structure. Adjuvants may similarly go about as the disturbance to attract and open up the body safe reaction.

•              Mineral salt adjuvants

•              Tensoactive adjuvants

•              Bacteria-derived adjuvants

•              Adjuvant emulsions

•              Liposome adjuvants

•              Polymeric microsphere adjuvants

•              Carbohydrate adjuvants

•              Cancer vaccine adjuvants

•              Mucosal Vaccines

Session 19 Current research and future difficulties:

Antibody advancement stays testing in light of the very complex avoidance instruments of pathogens for which immunizations are not yet accessible. Late years have seen the two victories and disappointments of novel immunization plan and the quality of iterative methodologies is progressively valued. These consolidate revelation of novel antigens, adjuvants and vectors in the preclinical stage with computational examinations of clinical information to quicken immunization outline. Switch and auxiliary vaccinology have uncovered novel antigen competitors and sub-atomic immunology has prompted the plan of promising adjuvants. Quality articulation profiles and invulnerable parameters in patients, vaccines, and solid controls have shaped the reason for bio-marks that will give rules to future immunization plan.

•              Immunological difficulties

•              Antigen revelation

•              Immunization courses

•              Aspects of pathology and host reactions

•              Expanded testing and displaying of antibody

•              Chloroplast-determined antibodies antigens and therapeutics

Market analysis

Global Vaccines Congress 2018 welcomes attendees, presenters, and exhibitors from all over the world to Rome, Italy. We are delighted to invite you all to attend and register for the “3rd Global Congress On Vaccines and Vaccination ” which is going to be held during November 14-15, 2018 in Rome, Italy. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposium, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at Global Vaccines Congress 2018, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Global Vaccines Congress 2018 organizing committee look forward to meeting you in Rome, Italy. Vaccines are turning into a motor for the pharmaceutical industry. More up to date and more costly immunizations are coming into the market speedier than any time in recent memory. Examines in immunizations are centered around new sickness targets and new advancement methodologies. Antibodies advancement is a mind-boggling, costly, and tedious process, regularly costing $500 at least million and spreading over quite a long while.


Vaccine Market by Technology (Live, Conjugate, Toxoid, Recombinant), Disease (Influenza, DTaP, HPV, Hepatitis, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, Rabies), Route (IM, SC, ID, Oral), End User (Pediatric, Adult) and Type - Forecast to 2022", The antibodies showcase is relied upon to achieve USD 49.27 Billion by 2022 from USD 34.30 Billion of every 2017, at a CAGR of 7.5%. The development of the market is ascribed to the rising predominance of illnesses, expanding government and nongovernment subsidizing for antibody improvement, and expanding ventures by organizations.

 In 2017, Europe is relied upon to hold the second biggest offer of this market. The investigation appraises the antibodies advertise estimate for 2017 and ventures its request till 2022. In the essential research process, different sources from both request side and supply side were met to acquire subjective and quantitative data for the report.

Organizing Committee
OCM Member
Segundo Mesa Castillo
Specialist in Neurology, Specialist in Neurology
Psychiatric Hospital of Havana, Cuba
Havana, Cuba
OCM Member
Giulio Tarro
Foundation de Beaumont Bonelli for cancer research
Naples, Italy
OCM Member
Dr Atmaram Bandivdekar
Professor, Department Of Reproductive Health
National Institute For Research of Reproductive Health
Mumbai, India
OCM Member
Dr. El Hadji Seydou Mbaye
Author of the world program against cancer , Cancer Research
3Cancer Institute, Aristide Le Dantec Hospital, Dakar, Senegal
Dakar, West Africa
OCM Member
Dr. Francis Enifo Oronsaye
Professor, Medical Microbiology
University of Benin
Lagos, Nigeria
OCM Member
Dr. Oksana Debrah
Deputy Chief Medical Laboratory Scientist, Medical Microbiology
Laboratory Department, Greater Accra Regional Hospital, Accra, Ghana
Kumasi , Ghana
OCM Member
Dr. K.M Yacob
Chief Physician, Healthcare
Marma Heatth Centre,Kochi ,Kerala,India
Trivandrum, India
OCM Member
Dr. Harshit Jain
Physician, Healthcare
McCann Health
London, United Kingdom
OCM Member
Dr. Jehad Zweiri
Professor, Department of Medicine
University of Liverpool School of Medicine
London, United Kingdom
OCM Member
Dr. Mamdouh Ibrahim Nassar
Research, Faculty of Science
Cairo University
Oula , Egypt
OCM Member
Dr. Mitja Vrdelja
Head Of Communication Department, Communication Department
National Institute of Public Health
Ljubljana, Slovenia
OCM Member
Sarah T. Idris
Medical Laboratory Specialist, Medical Laboratory
National Medicines and Poisons Board
Al-Gamaa Ave, Sudan

Hotel Mercure Roma West

Viale Eroi di Cefalonia, 301, 00128 Roma RM, Italy

Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
Sponsorship Opportunity
General EnQuiry
More details about

Terms and Conditions


Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.


Registration fees do not include insurance of any kind.


Please note that any (or) all transportation and parking is the responsibility of the registrant.


Press permission must be obtained from Allied Academies Conferences Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies Ltd is an objective third-party nonprofit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrant's account.

This cancellation policy was last updated on April 04, 2018.

Cancellation, Postponement, and Transfer of Registration

All cancellations or modifications of registration must be made in writing to

Cancellation Policy

If Allied Academies Group cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies Group event which must occur within one year from the date of cancellation.


If Allied Academies Group postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies Ltd event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization if the registered person is unable to attend the event. Transfers must be made by the registered person in writing to Details must be included the full name of replacement person, their title, contact phone number, and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies Ltd if the person is unable to attend one of the conferences.

However, Registration cannot be transferred if it is intimated within 14 days of the respective conference.

The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies Ltd will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies Ltd, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 90 days of the conference: Eligible for Full Refund less $100 Service Fee
  • Within 90-60 days of Conference: Eligible for 50% of payment Refund
  • Within 60 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies Ltd will advise the cancellation policy of your accommodation provider, prior to canceling or amending your booking, to ensure you are fully aware of any non-refundable deposits.


Authorization Policy

Copyright © 2019-2020 Allied Academies, All Rights Reserved.